Challenges and opportunities to end tuberculosis in the COVID-19 era

Research output: Contribution to journal › Comment/debate

29 Citations (Scopus)

Original language	English
Pages (from-to)	556-558
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	6
Early online date	24 Mar 2021
DOIs	https://doi.org/10.1016/s2213-2600(21)00161-2
Publication status	Published - 1 Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{29002f747aa544048a13100c4c9b8edc,

title = "Challenges and opportunities to end tuberculosis in the COVID-19 era",

author = "Tom Wingfield and Fatima Karmadwala and Peter MacPherson and Kerry Millington and Naomi Walker and Luis Cuevas and Bertie Squire",

year = "2021",

month = jun,

day = "1",

doi = "10.1016/s2213-2600(21)00161-2",

language = "English",

volume = "9",

pages = "556--558",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd",

number = "6",

}

TY - JOUR

T1 - Challenges and opportunities to end tuberculosis in the COVID-19 era

AU - Wingfield, Tom

AU - Karmadwala, Fatima

AU - MacPherson, Peter

AU - Millington, Kerry

AU - Walker, Naomi

AU - Cuevas, Luis

AU - Squire, Bertie

PY - 2021/6/1

Y1 - 2021/6/1

U2 - 10.1016/s2213-2600(21)00161-2

DO - 10.1016/s2213-2600(21)00161-2

M3 - Comment/debate

SN - 2213-2600

VL - 9

SP - 556

EP - 558

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 6

ER -